Document Detail


Structural modifications of (1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid, a potent irreversible inhibitor of GABA aminotransferase.
MedLine Citation:
PMID:  17267220     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Low brain levels of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) lead to convulsions. Inhibition of GABA aminotransferase increases the concentration of GABA and can terminate the convulsions. Earlier we reported the synthesis of (1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid (2), which is 186 times more potent an inactivator of GABA aminotransferase than the epilepsy drug S-vigabatrin. The corresponding dichloromethylene analogue of 2 (compound 3) has been made, but it shows only weak reversible inhibition of GABA aminotransferase. However, the tetrazole isostere of 2 (compound 4) has been found to be a time-dependent inactivator of GABA aminotransferase. Although it is 20 times less potent than carboxylic acid 2, it is 2.5 times more potent than S-vigabatrin. A calculation of the ClogP values indicates that 4 is the most lipophilic of the three, being 69 times more lipophilic than 2 and 55 times more lipophilic than S-vigabatrin, indicating potential for improved bioavailability.
Authors:
Hai Yuan; Richard B Silverman
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2007-01-17
Journal Detail:
Title:  Bioorganic & medicinal chemistry letters     Volume:  17     ISSN:  0960-894X     ISO Abbreviation:  Bioorg. Med. Chem. Lett.     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-02-23     Completed Date:  2007-05-29     Revised Date:  2010-09-20    
Medline Journal Info:
Nlm Unique ID:  9107377     Medline TA:  Bioorg Med Chem Lett     Country:  England    
Other Details:
Languages:  eng     Pagination:  1651-4     Citation Subset:  IM    
Affiliation:
Department of Chemistry, Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University, Evanston, IL 60208-3113, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
4-Aminobutyrate Transaminase / antagonists & inhibitors*
Carboxylic Acids / chemical synthesis*,  pharmacology*
Chemistry, Physical
Cyclopentanes / chemical synthesis*,  pharmacology*
Enzyme Inhibitors / chemical synthesis*,  chemistry,  pharmacology*
Kinetics
Physicochemical Phenomena
Structure-Activity Relationship
Grant Support
ID/Acronym/Agency:
GM 66132/GM/NIGMS NIH HHS; R01 GM066132-04/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
0/(1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid; 0/Carboxylic Acids; 0/Cyclopentanes; 0/Enzyme Inhibitors; EC 2.6.1.19/4-Aminobutyrate Transaminase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones.
Next Document:  Phenoxy thiazole derivatives as potent and selective acetyl-CoA carboxylase 2 inhibitors: Modulation...